David Moore to AIDS Dementia Complex
This is a "connection" page, showing publications David Moore has written about AIDS Dementia Complex.
Connection Strength
2,785
-
The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease. J Neurovirol. 2019 10; 25(5):661-672.
Score: 0,642
-
Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults. J Acquir Immune Defic Syndr. 2017 Mar 01; 74(3):243-249.
Score: 0,563
-
Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders. AIDS. 2021 01 01; 35(1):15-22.
Score: 0,184
-
Risk of developing cerebral ß-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 11 15; 33(14):2157-2166.
Score: 0,170
-
Sex differences in HIV-associated cognitive impairment. AIDS. 2018 11 28; 32(18):2719-2726.
Score: 0,159
-
Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 04 24; 31(7):973-979.
Score: 0,142
-
Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):134-141.
Score: 0,140
-
The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis. 2016 Sep 01; 63(5):694-702.
Score: 0,133
-
The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 Jul 31; 29(12):1483-91.
Score: 0,126
-
The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):190-7.
Score: 0,114
-
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr. 2013 Apr 15; 62(5):487-95.
Score: 0,108
-
Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013 Jan 22; 80(4):371-9.
Score: 0,106
-
Cerebral ß-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE e4 carriers. AIDS. 2012 Nov 28; 26(18):2327-35.
Score: 0,105
-
Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011 Aug 15; 57(5):371-9.
Score: 0,096